Journals / Anadolu Tıp Dergisi / 2000 / Cilt: 2 - Sayı: 2

The effects of sertraline on anxiety by the plus maze test

Sertralinin artı labirent testinde anksiyete üzerine etkileri

Pages
97–100
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the first group no effects were observed, but in the second and the third groups the duration of time that the mice spent in the open arm decreased significantly (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the effects of sertraline, that was applied acutely or chronically, on anxiety of mice were investigated by plus maze method.
📊
Key Findings & Data:Eight groups of mice, of which weights were ranged between 25-40 g, were formed.
💡
Conclusion & Impact:In the first group no effects were observed, but in the second and the third groups the duration of time that the mice spent in the open arm decreased significantly (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, the effects of sertraline, that was applied acutely or chronically, on anxiety of mice were investigated by plus maze method. Eight groups of mice, of which weights were ranged between 25-40 g, were formed. A single dose of 5 and 10 mg sertraline was administered intraperitoneally to the first and second groups, respectively. Sertraline was administered intraperitoneally to the third and fourth groups, chronically for seven and 14 days respectively. 2 mg/kg diazepam was administered to the fifth group and serum physiologic was given to the control groups (groups VI, VII, VIII). In the first group no effects were observed, but in the second and the third groups the duration of time that the mice spent in the open arm decreased significantly (p

Özet

Bu çalışmada farelerde tek doz ve kronik verilen sertralinin anksiyete üzerine etkileri artı labirent yöntemi ile araştırılmıştır. Ağırlıkları 25-40 g arasında olan beyaz farelerden 8 grup oluşturulmuş, I. ve II. gruplara 5 ve 10 mg/kg dozlarında akut, III. ve IV. gruplara ise sırasıyla 7 ve 14 gün sürelerle 5 mg/kg/gün dozunda kronik sertralin verilmiştir. Beşinci gruba diazepam (2 mg/kg) verilmiştir. Kontrol gruplarına (VI., VII., VIII.) ise serum fizyolojik verilmiştir. Tek doz sertralin verilen gruplardan ilkinde (5 mg/kg) herhangi bir etki saptanmamış, ikincisinde (10 mg/kg) ise farelerin açık kollarda geçirdikleri süre kontrol grubuna göre anlamlı olarak azalmıştır (p

🔖

Cite This Article

ÖZDEMİR, G., ÇELİK, S., KURT, M., ARIK, A. C. (2022). The effects of sertraline on anxiety by the plus maze test. Anadolu Tıp Dergisi, Cilt: 2 - Sayı: 2, 97–100. https://ajindex.com/articles/438202

References (15)

  1. Baldwin H, File S. Caffeine-induced anxiogenesis: The role of adenosine, benzodiazepine and noradrenergic receptors. Pharm Biochem and Behav 1989:32.181-6
  2. Byerley WF, Reimfer FW, Wood RD.et al. Fluoxetine a selective serotoinin uptake inhibitor for the treatment of outpatients with major depression. J Clin Psychopharmacology 1988;8:112-5
  3. Doogan DR, Caillard V. Sertraline: A new antidepressant. J Clin Psychiatry 1988;49 (suppl): 222-5
  4. Griebel G, Moreau JL. Jenck F. Evidence that tolerance to the anxiogenic-like effects of m-CPP does not involve alteration in the function of 5-HT2c receptors in the rat choroid plexus. Behavioural Pharmacology 1994;5: 642-5
  5. Heym J, Koe BK. Pharmacology of sertraline: A review. J Clin Psychiatry 1988;49(supp):40-5
  6. Kennedy AJ, Gibson EL, O'Connell MT, et al. Effects of housing, restraint and chronic treatments with m-CPP and sertraline on behavioural responses to m-CPP. Psychopharmacology 1993:113(2): 262-8
  7. Kennet GA, Bright F, Trait B. Anxiolytic-like actionsof the selective 5-HT4 receptor antagonists SB 204070A and 207266A in rats.Neuropharmacology 1997; 36(4/5):702-17
  8. Kırpınar İ. Anksiyete bozukluklarının etiyolojisi,Anksiyete monograflan. 1995;2:55-96
  9. Koe BK. Preclinical pharmacology of sertraline: a potent and spesific inhibitor of serotonin reuptake. J Clin Psychiatry 1990;51(suppB):13-7. 10.Lister RG. The use of plus-maze to measure anxiety in the mouse. Psychopharmacology 1987:92:180-185
  10. LuckyiI, serotonin receptor specificity in anxiety disorders. J Clin Psychiatry 1996;57:5-10 12. Montgomery S A, Doogan DR, Burnside R.The influence of different relapse criteria on the assesment of the long-term efficacy of sertraline.Int Clin Psychopharmacology 1991;6(suppl 2):37-46
  11. Pellow S, FileS. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. PharmacolBiochem and Behav 1986;24:524-9
  12. Preskorn SH. Targetet pharmacotherapy in depressionmanagement: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline Int Clin Psychopharmacology 1994;9 (suppl 3): 13-9
  13. Roychoudhury M, Kulkarni SK. Antianxiety profile of ondansetron,a selective 5-HT3 antagonist, in a new animal model Meth and Find Exp Clin pharmaco 1997; 19(2): 107-11
  14. Seale TW, Nickrasz I. Anxiolysis by ethanol,diazepam and buspirone in a novel murine behavioral assay. Neuroreport 1996;7:1803-8
  15. Wernicke JF, Dunlop S, Dornseir B, e